San Antonio Breast Cancer Symposium 2009

In this issue:

Exemestane alone vs the Switch Approach
as initial adjuvant therapy
Optimising extended adjuvant letrozole
Alcohol affects breast cancer survival?
Obesity worsens breast cancer prognosis
Bisphosphonates reduce breast cancer incidence?
Denosumab promising for bone metastases
CYP2D6 and tamoxifen clinical outcome
Adding bevacizumab to docetaxel improves PFS
Sorafenib + capecitabine for HER2-negative mBC
Lapatinib + trastuzumab improves mBC survival
No need for anthracycline with trastuzumab?
Trastuzumab: New duration and sequence data

Download PDF Subscribe